Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.

Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer. Clin Cancer Res. 2000 Jan; 6(1):278-84.

View in: PubMed

subject areas

Adenoviridae
Annexin A5
Apoptosis
bcl-2-Associated X Protein
Cell Adhesion
Cell Cycle
Cell Division
Cyclin-Dependent Kinase Inhibitor p21
Cyclins
Cystadenocarcinoma, Papillary
Endometrial Neoplasms
Enzyme Inhibitors
Female
Genes, p53
Genetic Therapy
Genetic Vectors
Humans
In Situ Nick-End Labeling
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-bcl-2
Transfection
Tumor Cells, Cultured
Tumor Suppressor Protein p53

authors with profiles

THOMAS W BURKE
GORDON B MILLS
LOIS M RAMONDETTA